137 related articles for article (PubMed ID: 8132440)
21. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
[TBL] [Abstract][Full Text] [Related]
22. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.
Hudson JI; McElroy SL; Raymond NC; Crow S; Keck PE; Carter WP; Mitchell JE; Strakowski SM; Pope HG; Coleman BS; Jonas JM
Am J Psychiatry; 1998 Dec; 155(12):1756-62. PubMed ID: 9842788
[TBL] [Abstract][Full Text] [Related]
23. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.
McDougle CJ; Naylor ST; Cohen DJ; Volkmar FR; Heninger GR; Price LH
Arch Gen Psychiatry; 1996 Nov; 53(11):1001-8. PubMed ID: 8911223
[TBL] [Abstract][Full Text] [Related]
24. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
Mundo E; Guglielmo E; Bellodi L
Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
[TBL] [Abstract][Full Text] [Related]
25. Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases.
Horii A; Uno A; Kitahara T; Mitani K; Masumura C; Kizawa K; Kubo T
J Vestib Res; 2007; 17(1):1-8. PubMed ID: 18219099
[TBL] [Abstract][Full Text] [Related]
26. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
[TBL] [Abstract][Full Text] [Related]
27. Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder.
Heidari M; Zarei M; Hosseini SM; Taghvaei R; Maleki H; Tabrizi M; Fallah J; Akhondzadeh S
Int Clin Psychopharmacol; 2014 Nov; 29(6):344-50. PubMed ID: 24850229
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder.
Turkington D; Grant JB; Ferrier IN; Rao NS; Linsley KR; Young AH
J Clin Psychiatry; 2002 Sep; 63(9):778-81. PubMed ID: 12363117
[TBL] [Abstract][Full Text] [Related]
29. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
Zohar J; Keegstra H; Barrelet L
Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
[TBL] [Abstract][Full Text] [Related]
30. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
Feighner JP; Boyer WF; Meredith CH; Hendrickson GG
Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
[TBL] [Abstract][Full Text] [Related]
31. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
Stein MB; Fyer AJ; Davidson JR; Pollack MH; Wiita B
Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
[TBL] [Abstract][Full Text] [Related]
32. [Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin].
Riesner HJ; Zeitler C; Schreiber H; Wild A
Z Orthop Unfall; 2008; 146(6):742-6. PubMed ID: 19085723
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
Hollander E; Koran LM; Goodman WK; Greist JH; Ninan PT; Yang H; Li D; Barbato LM
J Clin Psychiatry; 2003 Jun; 64(6):640-7. PubMed ID: 12823077
[TBL] [Abstract][Full Text] [Related]
34. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
Ushiroyama T; Ikeda A; Ueki M
J Med; 2004; 35(1-6):151-62. PubMed ID: 18084873
[TBL] [Abstract][Full Text] [Related]
36. [Fluoxetine versus fluvoxamine for treatment of chronic pain].
Ciaramella A; Grosso S; Poli P
Minerva Anestesiol; 2000; 66(1-2):55-61. PubMed ID: 10736983
[TBL] [Abstract][Full Text] [Related]
37. Suicidal risk during controlled clinical investigations of fluvoxamine.
Letizia C; Kapik B; Flanders WD
J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
[TBL] [Abstract][Full Text] [Related]
38. A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients.
Rahman MK; Akhtar MJ; Savla NC; Sharma RR; Kellett JM; Ashford JJ
Br J Clin Pract; 1991; 45(4):255-8. PubMed ID: 1810358
[TBL] [Abstract][Full Text] [Related]
39. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study.
Zanardi R; Franchini L; Gasperini M; Lucca A; Smeraldi E; Perez J
J Clin Psychopharmacol; 1998 Dec; 18(6):441-6. PubMed ID: 9864075
[TBL] [Abstract][Full Text] [Related]
40. Chronic muscle contraction headache: the importance of depression and anxiety.
Hackett GI; Boddie HG; Harrison P
J R Soc Med; 1987 Nov; 80(11):689-91. PubMed ID: 3320366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
